ArticleCurrent microbiology2025
The β-1,6-glucanase MoGlu16 is Required for Mycelia Growth and Pathogenicity of Magnaporthe oryzae.
Article in Current microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Structure, Biosynthesis, and Function of β-1,6-Glucan in the Fungal Cell Wall.Biomolecules · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Fungal cell wall is essential in orchestrating fungal morphogenesis and sensing environmental stimuli. Its dynamic reconstruction involves glycoside hydrolases, particularly β-1,6-glucanase, which is crucial for synthesis of β-1,6-glucan. This glucan functions as a fundamental structural element within the fungal cell wall, covalently linking mannoproteins into the β-1,3-glucan-chitin network. Previously, a highly hydrolytically active β-1,6-glucanase, MoGlu16, was identified in Magnaporthe oryzae. However, its impacts on the pathogenicity of the blast fungus remain unexplored. In this study, to elucidate the detailed biological function of this protein, we generated the ΔMoglu16 mutant strain by knocking out the MoGLU16 gene encoding the β-1,6-glucanase via homologous recombination. Compared to the wild-type strain Guy11, ΔMoglu16 mutant exhibited a significantly slower vegetative growth rate, with a reduction of approximately 52% on MM medium. Its cell wall structure was altered, characterized by a 13.7% decrease in β-1,6-glucan content and a 12.2% increase in chitin. Furthermore, the mutant displayed increased sensitivity to cell wall-disturbing agents. In addition, the deletion of MoGLU16 exerted a minor influence on the early developmental stages of conidia, but severely compromised M. oryzae infection and pathogenicity. These findings suggested that MoGlu16 was essential for mycelial growth and pathogenicity of M. oryzae, thereby providing a crucial theoretical basis for the development of novel fungicides targeting β-1,6-glucan.
Indexed as
Identifiers
41291040What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.